NPNT
Basic information
Region (hg38): 4:105894774-106004027
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NPNT gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 36 | 42 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 37 | 8 | 0 |
Variants in NPNT
This is a list of pathogenic ClinVar variants found in the NPNT region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-105895659-T-G | not specified | Uncertain significance (Nov 14, 2023) | ||
4-105895680-G-A | not specified | Uncertain significance (May 26, 2022) | ||
4-105895711-A-C | not specified | Uncertain significance (Jul 25, 2023) | ||
4-105895711-A-G | not specified | Uncertain significance (Dec 27, 2022) | ||
4-105895717-A-T | not specified | Uncertain significance (Oct 10, 2023) | ||
4-105897902-T-G | not specified | Uncertain significance (Apr 06, 2024) | ||
4-105897932-C-T | Likely benign (Feb 01, 2023) | |||
4-105897938-C-T | not specified | Uncertain significance (Apr 20, 2023) | ||
4-105897939-G-A | not specified | Uncertain significance (Jul 14, 2023) | ||
4-105897954-T-C | not specified | Uncertain significance (May 18, 2022) | ||
4-105897978-G-A | not specified | Uncertain significance (Dec 14, 2023) | ||
4-105927417-C-T | not specified | Uncertain significance (Dec 18, 2023) | ||
4-105937013-A-C | Likely benign (Mar 01, 2023) | |||
4-105938318-A-G | not specified | Uncertain significance (May 04, 2022) | ||
4-105938337-G-T | not specified | Uncertain significance (Apr 23, 2024) | ||
4-105938382-C-T | Likely benign (Mar 01, 2023) | |||
4-105938384-G-A | not specified | Uncertain significance (Feb 15, 2023) | ||
4-105940089-G-A | not specified | Uncertain significance (Dec 16, 2023) | ||
4-105940111-C-T | not specified | Uncertain significance (Jun 11, 2024) | ||
4-105940159-G-A | not specified | Uncertain significance (Jan 03, 2022) | ||
4-105940173-G-A | not specified | Uncertain significance (Dec 07, 2021) | ||
4-105940181-G-A | not specified | Uncertain significance (Jan 23, 2023) | ||
4-105940562-G-A | not specified | Uncertain significance (Sep 30, 2021) | ||
4-105940571-A-G | not specified | Uncertain significance (Feb 26, 2024) | ||
4-105940587-C-G | Uncertain significance (Mar 25, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NPNT | protein_coding | protein_coding | ENST00000427316 | 13 | 109253 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.73e-10 | 0.896 | 125697 | 0 | 51 | 125748 | 0.000203 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.0940 | 341 | 336 | 1.01 | 0.0000175 | 3851 |
Missense in Polyphen | 116 | 132.97 | 0.87237 | 1581 | ||
Synonymous | 0.610 | 111 | 119 | 0.929 | 0.00000638 | 1168 |
Loss of Function | 1.85 | 20 | 31.1 | 0.642 | 0.00000156 | 368 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000268 | 0.000268 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000440 | 0.000435 |
Finnish | 0.0000467 | 0.0000462 |
European (Non-Finnish) | 0.000252 | 0.000246 |
Middle Eastern | 0.000440 | 0.000435 |
South Asian | 0.000171 | 0.000163 |
Other | 0.000343 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Functional ligand of integrin alpha-8/beta-1 in kidney development. Regulates the expression of GDNF with integrin alpha- 8/beta-1 which is essential for kidney development. May also play a role in the development and function of various tissues, regulating cell adhesion, spreading and survival through the binding of several integrins (By similarity). {ECO:0000250}.;
- Pathway
- Beta1 integrin cell surface interactions
(Consensus)
Recessive Scores
- pRec
- 0.100
Intolerance Scores
- loftool
- 0.124
- rvis_EVS
- 1.8
- rvis_percentile_EVS
- 96.93
Haploinsufficiency Scores
- pHI
- 0.183
- hipred
- N
- hipred_score
- 0.267
- ghis
- 0.424
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.419
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Npnt
- Phenotype
- renal/urinary system phenotype;
Zebrafish Information Network
- Gene name
- npnt
- Affected structure
- atrioventricular valve
- Phenotype tag
- abnormal
- Phenotype quality
- increased length
Gene ontology
- Biological process
- ureteric bud development;branching involved in ureteric bud morphogenesis;cell-matrix adhesion;positive regulation of alkaline phosphatase activity;positive regulation of cell-substrate adhesion;extracellular matrix organization;positive regulation of transforming growth factor beta receptor signaling pathway;cell-cell adhesion mediated by integrin;establishment of protein localization;positive regulation of osteoblast differentiation;positive regulation of smooth muscle contraction;positive regulation of ERK1 and ERK2 cascade;cellular response to tumor necrosis factor;pilomotor reflex;positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation
- Cellular component
- extracellular region;basement membrane;smooth muscle contractile fiber;integrin alpha8-beta1 complex;collagen-containing extracellular matrix;extracellular exosome
- Molecular function
- integrin binding;extracellular matrix structural constituent;calcium ion binding